Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1.4M
2 rounds on record
Latest round
$1.4M
Venture round · Sep 2022 · 4 yr ago
Team
1-10
employees, estimated range
Grants
$256k
1 grant · CORDIS
The money's age
Long since its last round
49 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 19, 2022 Raised a round Venture round $1.4M · SEC Form D Feb 15, 2022 Won a grant $256k · CORDIS 2019 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2022 $1.4M — SEC Form D
Grant Feb 2022 $256k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity Diant Pharma Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Diane BurgessExecutive Officer, DirectorSEC Form D
Antonio CostaExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
OurvitaFounded 2009
The Global CDMO partner you can trust to deliver. We develop and manufacture food supplements, medical devices, cosmetics and probiotics.
Inside TherapeuticsFounded 2023 • 11-50 employees
Inside Therapeutics is a company specialized in providing system for nanoparticle synthesis or nanoparticle manufacturing using…
Checker SpotVenture round $27.4M · 2 mo ago • Founded 2016
Checkerspot is a category defining biotechnology company specializing in the design and production of fats and oils through precision…
Supporting creators of high-quality supplements so the world can enjoy better health and well-being. • TGA Certified • ISO 17025:2017…
Vivacta bioSeries A · 5 mo ago • 51-200 employees
微滔生物成立于2025年6月25日,其前身系沙砾集团为自主研发的体内CAR-T平台独立运营而成。微滔生物将基于T 靶向 LNP 递送系统开发in vivo CAR-T管线,专注于非病毒体内靶向细胞治疗业务,该业务主要用于血液瘤及自身免疫疾病治疗。.
クオリプス(Cuorips)は、iPS細胞技術を活用した再生医療等製品の研究開発・製造を行う企業です。ヒト(同種) iPS 細胞由来心筋細胞の商用化や、高度な培養技術を活かした製造受託(CDMO)を展開。医学・医療の発展に貢献し、「いのち」と「笑顔」を広げます。.

Overview

DIANT® offers innovators and CDMOs turnkey nanoparticle / LNP manufacturing solutions and R&D services that increase speed to market.

People

Diane Burgess
Executive Officer, Director
Antonio Costa
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Manchester United States
HQ
1-10 est. staff

Financials

Total raised
$1.7M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $1.4M Details
Grant 2022 $256k Details